跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NH-34
首页
药物
NH-34
NH-34
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Double-Acylated GLP-1 Derivatives
US 2015152157 A1
申请人: NOVO NORDISK AS
优先权: 2013
CN
US
3 件公开
GLP-1 derivative and preparation thereof absorbable via mucous membrane
US 7291594 B2
申请人: SANWA KAGAKU KENKYUSHO CO
优先权: 2002
US
2 件公开
Cosmetic preparations containing PTH fragments
US 9387235 B2
申请人: MOUSSOU PHILIPPE
优先权: 2004
US
2 件公开
ANTI-ADM-ANTIBODIES BINDING TO THE FREE N-TERMINUS FOR ACCELERATED TRANSITION OF ADM-GLY TO BIO-ADM IN PATIENTS WITH ADM-GLY/ BIO-ADM RATIO ABOVE A THRESHOLD AND COMBINATION WITH VITAMIN C
EP 3871689 A1
申请人: SPHINGOTEC GMBH
优先权: 2020
EP
2 件公开
Heterocyclic compounds and their pharmaceutical use
EP 1661564 A1
申请人: SOD CONSEILS RECH APPLIC
优先权: 2000
EP
Chemical compounds
US 2005107428 A1
申请人: ALCARAZ LILIAN
优先权: 2002
US
(2,4,9-TRIAZA-1(2,4)-PYRIMIDINA-3(1,3)-BENZENACYCLONONAPHAN-3^4-YL)-SULFOXIMIDE DERIVATIVES AS SELECTIVE INHIBITORS OF THE AURORA KINASE FOR THE TREATMENT OF CANCER
EP 1803723 A1
申请人: BAYER SCHERING PHARMA AG
优先权: 2006
EP
Dihydrothienopyrimidines for the treatment of inflammatory diseases
EP 1847543 A1
申请人: BOEHRINGER INGELHEIM PHARMA
优先权: 2006
EP
METHOD OF DRUG DELIVERY FOR PTH, PTHRP AND RELATED PEPTIDES
EP 3332799 A1
申请人: RADIUS HEALTH INC
优先权: 2011
EP
GLP-1R/GIPR/GCGR TRIPLE AGONIST ANALOGUE AND USE THEREOF
EP 4790066 A1
申请人: SHENZHEN BAY LABORATORY
优先权: 2023
EP
药物
反馈